Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- FRPT +11.1%, BCRX +9.4%, L +4%, JLL +2.7%
Other news:
- PRFT +52.5% (to be Acquired by EQT for $76.00 per share; also reported earnings)
- ZTEK +10.6% (subsidiary Triera Biosciences prioritized the development of a prophylaxis and therapeutic for highly pathogenic avian influenza and reports initial test results)
- LILM +8.7% (files for 75 mln share offering by selling shareholder)
- HIMS +5.7% (CEO says that he "in no way condone nor support acts or threats of violence, antisemitism, or intimidation and there is absolutely no justification for violence on our campuses")
- XERS +4.8% (has entered into an exclusive worldwide collaboration and license agreement with Beta Bionics for the development and commercialization of a glucagon product utilizing Xeris' XeriSol technology for use in Beta Bionics' proprietary bi-hormonal pump and pump systems)
- VST +4.4% (to join S&P 500)
- MNMD +3.9% (Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder)
- HUT +3.9% (provides operations update for April)
- CLLS +3.7% (Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca (AZN))
- URGN +3.2% (reports New Real-World Retrospective Analysis Presented at AUA 2024 Reports 86% Recurrence-Free Survival (RFS) at 24 Months with JELMYTO Across All Studied Patient and Disease Characteristics in Cohort of Responders to Induction Therapy; Results from ATLAS Showing Robust UGN-102 Durability of Response in New and Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer at AUA 2024)
- MNKD +3% (receives FDA fast track designation for clofazimine inhalation suspension for the treatment of nontuberculous mycobacterial lung disease)
- VZLA +2.9% (has now issued 448,137 common shares for the previously announced asset purchase agreement dated March 5, 2024, entered into with Inca Azteca Gold S.A.P.I. de C.V)
- REVG +1.9% (favorable research report from Alta Fox)
- WT +1.7% (sends letter to stockholders urging full support of the current board to continue the company's strong momentum)
- X +1.6% (EU Commission clears acquisition of US Steel by Nippon Steel)
- VALE +1.2% (informs on settlement proposal)
- CLF +1.1% (unit received an Order from MSHA at the Company's operations in Michigan)